摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-bromo-5-[(tetrahydro-2H-pyran-2-yloxy)-methyl]pyridine | 288372-63-4

中文名称
——
中文别名
——
英文名称
2-bromo-5-[(tetrahydro-2H-pyran-2-yloxy)-methyl]pyridine
英文别名
2-[(2-Bromopyridin-5-yl)methoxy]tetrahydro-2H-pyran;2-bromo-5-(oxan-2-yloxymethyl)pyridine
2-bromo-5-[(tetrahydro-2H-pyran-2-yloxy)-methyl]pyridine化学式
CAS
288372-63-4
化学式
C11H14BrNO2
mdl
——
分子量
272.142
InChiKey
HMUPAFGLFJISNV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    31.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-bromo-5-[(tetrahydro-2H-pyran-2-yloxy)-methyl]pyridine氢溴酸 、 palladium diacetate 、 R-(+)-1,1'-联萘-2,2'-双二苯膦sodium t-butanolate 作用下, 以 甲苯 为溶剂, 反应 27.0h, 生成
    参考文献:
    名称:
    Synthesis and Structure–Activity Relationships for Extended Side Chain Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
    摘要:
    Novel extended side chain nitroimidazooxazine analogues featuring diverse linker groups between two aryl rings were studied as a potential strategy to improve solubility and oral activity against chronic infection by Mycobacterium tuberculosis. Both lipophilic and highly polar functionalities (e.g., carboxamide, alkylamine, piperazine, piperidine, but not sulfonamide) were well tolerated in vitro, and the hydrophilic linkers provided some solubility improvements, particularly in combination with pyridine rings. Most of the 18 compounds further assessed showed high microsomal stabilities, although in the acute infection mouse model, just one stilbene (6-fold) and two pyridine-containing acetylene derivatives (5-fold and >933-fold) gave in vivo efficacies notably superior to the clinical stage compound pretomanid (PA-824). The most efficacious analogue also displayed outstanding in vivo activity in the stringent chronic model (up to 24-fold better than the drug delamanid and 4-fold greater than our previous best phenylpyridine candidate), with favorable pharmacokinetics, including good oral bioavailability in the rat.
    DOI:
    10.1021/jm501608q
  • 作为产物:
    描述:
    3,4-二氢-2H-吡喃6-溴-3-羟甲基吡啶对甲苯磺酸 作用下, 以 氯仿 为溶剂, 以81%的产率得到2-bromo-5-[(tetrahydro-2H-pyran-2-yloxy)-methyl]pyridine
    参考文献:
    名称:
    蛋白质-无机阵列构建:构建模块的设计和合成
    摘要:
    在这里,我们描述了用于无机蛋白质骨架定向构建的第一系列双功能配体的设计和合成。合成的配体由结合到环氧琥珀酰肽上的金属离子结合部分(基于吡啶)组成,已知该肽通过活性位点的半胱氨酸与活性半胱氨酸蛋白酶共价结合。我们探索并优化了双官能化金属离子配体与含环氧琥珀酰的肽部分之间的两种不同的缀合化学:肽键形成(成功有限)和Cu I催化的点击化学(良好结果)。此外,合成的配体与Fe II和Ni II的络合对离子进行了研究:证实双功能配体的行为与母体吡啶相同。按照设计,尽管单击反应产生了两个三唑环,但肽部分不会干扰络合反应。ES‐MS与NMR和UV / Vis研究一起确定了结构,络合反应的化学计量,以及对化学敏感的含多肽的聚吡啶配体进行自组装的条件。这些结果确立了我们方法的多功能性,并为合成含有更多精心设计的聚吡啶配体以及针对不同酶家族的亲和标记物的双功能配体开辟了道路。因此,
    DOI:
    10.1002/chem.200902649
点击查看最新优质反应信息

文献信息

  • Organosilicon compounds and uses thereof
    申请人:Northwestern University
    公开号:US06416861B1
    公开(公告)日:2002-07-09
    A compound of the formula: and a resin-bound compound of the formula: and their use in combinatorial chemistry and in the synthesis of compounds comprising at least one aromatic moiety is described, where R1, R2, R3, R4, R5, R6, R7, L1, P, Ar1, and X are as herein defined.
    本文描述了一个公式的化合物:以及一个公式的树脂结合化合物:以及它们在组合化学和合成至少含有一个芳香基团的化合物中的应用,其中R1,R2,R3,R4,R5,R6,R7,L1,P,Ar1和X的定义如本文所述。
  • US6416861B1
    申请人:——
    公开号:US6416861B1
    公开(公告)日:2002-07-09
  • [EN] ORGANOSILICON COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSES D'ORGANOSILICIES ET LEURS UTILISATIONS
    申请人:UNIV NORTHWESTERN
    公开号:WO2000049022A2
    公开(公告)日:2000-08-24
    A compound of formula (I) and a resin-bound compound of formula (II): and their use in combinatorial chemistry and in the synthesis of compounds comprising at least one aromatic moiety is described, where R?1, R2, R3, R4, R5, R6, R7, L1, P, Ar1¿, and X are as herein defined.
  • Synthesis and Structure–Activity Relationships for Extended Side Chain Analogues of the Antitubercular Drug (6<i>S</i>)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5<i>H</i>-imidazo[2,1-<i>b</i>][1,3]oxazine (PA-824)
    作者:Brian D. Palmer、Hamish S. Sutherland、Adrian Blaser、Iveta Kmentova、Scott G. Franzblau、Baojie Wan、Yuehong Wang、Zhenkun Ma、William A. Denny、Andrew M. Thompson
    DOI:10.1021/jm501608q
    日期:2015.4.9
    Novel extended side chain nitroimidazooxazine analogues featuring diverse linker groups between two aryl rings were studied as a potential strategy to improve solubility and oral activity against chronic infection by Mycobacterium tuberculosis. Both lipophilic and highly polar functionalities (e.g., carboxamide, alkylamine, piperazine, piperidine, but not sulfonamide) were well tolerated in vitro, and the hydrophilic linkers provided some solubility improvements, particularly in combination with pyridine rings. Most of the 18 compounds further assessed showed high microsomal stabilities, although in the acute infection mouse model, just one stilbene (6-fold) and two pyridine-containing acetylene derivatives (5-fold and >933-fold) gave in vivo efficacies notably superior to the clinical stage compound pretomanid (PA-824). The most efficacious analogue also displayed outstanding in vivo activity in the stringent chronic model (up to 24-fold better than the drug delamanid and 4-fold greater than our previous best phenylpyridine candidate), with favorable pharmacokinetics, including good oral bioavailability in the rat.
  • Protein-Inorganic Array Construction: Design and Synthesis of the Building Blocks
    作者:Niculina D. Bogdan、Mihaela Matache、Veronika M. Meier、Cristian Dobrotă、Ioana Dumitru、Gheorghe D. Roiban、Daniel P. Funeriu
    DOI:10.1002/chem.200902649
    日期:2010.2.15
    Herein we describe the design and synthesis of the first series of di‐functional ligands for the directed construction of inorganic‐protein frameworks. The synthesized ligands are composed of a metal‐ion binding moiety (terpyridine‐based) conjugated to an epoxysuccinyl peptide, known to covalently bind active cysteine proteases through the active‐site cysteine. We explore and optimize two different
    在这里,我们描述了用于无机蛋白质骨架定向构建的第一系列双功能配体的设计和合成。合成的配体由结合到环氧琥珀酰肽上的金属离子结合部分(基于吡啶)组成,已知该肽通过活性位点的半胱氨酸与活性半胱氨酸蛋白酶共价结合。我们探索并优化了双官能化金属离子配体与含环氧琥珀酰的肽部分之间的两种不同的缀合化学:肽键形成(成功有限)和Cu I催化的点击化学(良好结果)。此外,合成的配体与Fe II和Ni II的络合对离子进行了研究:证实双功能配体的行为与母体吡啶相同。按照设计,尽管单击反应产生了两个三唑环,但肽部分不会干扰络合反应。ES‐MS与NMR和UV / Vis研究一起确定了结构,络合反应的化学计量,以及对化学敏感的含多肽的聚吡啶配体进行自组装的条件。这些结果确立了我们方法的多功能性,并为合成含有更多精心设计的聚吡啶配体以及针对不同酶家族的亲和标记物的双功能配体开辟了道路。因此,
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-